Snowball logo
logo
VTGN_logo

VistaGen Therapeutics Inc

VTGN β€’ NASDAQ
$0.1738-$0.0059Β  (3.28%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20222023202420252026TTM
Revenue
Total revenue
1.1089(0.2273)1.0640.4861.2692.502
COGS
0.81520.50980.5680.635--
Gross Profit
1.1089(0.2273)1.0640.4861.2692.116
Operating Expenses & Income
Operating Income
(47.78)(59.27)(33.02)(55.97)(72.13)(69.66)
Total Operating Expenses
48.8959.0434.0956.4673.3971.78
R&D Expenses
35.4144.3820.0239.3854.9754.05
Selling General & Admin Expenses
10.4514.6614.0617.0818.4217.93
Earnings from Continuing Operations
Interest Expense
(0.232)(0.023)----
Interest Income
0.020.02623.3514.5572.4412.048
Income Tax Expense
0.00340.00590.0040.0070.0070.007
Net Income
Net Income
(47.76)(59.25)(29.36)(51.42)(69.69)(67.62)
Supplemental
EBIT
(47.76)(59.27)(29.36)(51.41)(72.13)(68.06)
EBITDA
(47.05)(58.74)(28.79)(50.78)(71.39)(67.3)
In millions of USD, except % and values per 1 share